期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
终末期肾病血液透析患者血浆COMP表达与动静脉内瘘失功及预后的相关性研究 被引量:2
1
作者 周宗祥 张红 《临床肾脏病杂志》 2022年第1期22-27,共6页
目的检测终末期肾病(end-stage renal disease,ESRD)血液透析患者血浆软骨寡聚基质蛋白(cartilage oligomeric matrix protein,COMP)表达,并分析COMP与动静脉内瘘(arteriovenous fistula,AVF)失功及预后的相关性。方法选取2015年2月至2... 目的检测终末期肾病(end-stage renal disease,ESRD)血液透析患者血浆软骨寡聚基质蛋白(cartilage oligomeric matrix protein,COMP)表达,并分析COMP与动静脉内瘘(arteriovenous fistula,AVF)失功及预后的相关性。方法选取2015年2月至2017年2月于山东省枣庄市中医医院血液透析中心行AVF手术的150例ESRD患者作为研究对象,根据AVF是否失功将患者分为通畅组(98例)和失功组(52例),取其手术过程中的桡动脉残端,根据钙化情况分为钙化组66例与无钙化组84例,通过Spearman法分析患者血管钙化与AVF的关系,收集受试者一般资料,全自动生化分析仪检测受试者血尿素氮(blood urea nitrogen,BUN)、血肌酐(serum creatinine,Scr)、尿酸(uric acid,UA)水平。采用酶联免疫吸附法(enzyme-linked immunosorbent assay,ELISA)检测受试者血浆COMP水平。采用受试者工作特征曲线(receiver operating characteristic curve,ROC)分析血浆COMP水平对ESRD患者发生血管钙化及AVF失功的预测价值。用Kaplan-Meier法分析血浆COMP水平与ESRD患者预后的关系。COX回归分析影响ESRD患者预后的危险因素。结果通畅组血浆COMP水平低于失功组(P<0.05),无血管钙化组血浆COMP水平低于血管钙化组(P<0.05),AVF失功与血管钙化呈正相关(r=0.526,P<0.05)。ROC分析结果显示,血浆COMP预测ESRD患者发生血管钙化的曲线下面积(AUC)为0.827(95%CI:0.748~0.906),预测ESRD患者发生AVF失功的AUC为0.865(95%CI:0.795~0.936)。K-M法分析显示,ESRD患者3年累积生存率为69.33%(104/150),COMP高表达患者3年累积生存率低于COMP低表达患者(59.46%比78.95%,χ^(2)=8.525,P<0.05)。多因素COX分析显示,COMP水平偏高是ESRD患者不良预后的危险因素(HR=3.559,P<0.05)。结论ESRD血液透析患者血浆COMP水平升高,对ESRD血液透析患者血管钙化、AVF失功具有预测价值,是ESRD血液透析患者预后不良的危险因素,可能作为ESRD患者预后的标志物。 展开更多
关键词 终末期肾病 软骨寡聚基质蛋白 动静脉内瘘
下载PDF
A novel full-length gene of human ribosomal protein L14.22 related to human glioma
2
作者 QI Zhen-yu HUI Guo-zhen +3 位作者 LI Yao zhou zong-xiang GU Shao-hua XIE Yi 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第16期1353-1358,共6页
Background This study was undertaken to obtain differentially expressed genes related to human glioma by cDNA microarray and the characterization of a novel full-length gene. Methods Total RNA was extracted from human... Background This study was undertaken to obtain differentially expressed genes related to human glioma by cDNA microarray and the characterization of a novel full-length gene. Methods Total RNA was extracted from human glioma and normal brain tissues, and mRNA was used as a probe. The results of hybridization procedure were scanned with the computer system. The gene named 507E08 clone was subsequently analyzed by northern blot, bioinformatic approach, and protein expression. Results Fifteen differentially expressed genes were obtained from human glioma by hybridization and scanning for four times. Northern blot analysis confirmed that the 507E08 clone was low expressed in human brain tissue and over expressed in human glioma tissues. The analysis of BLASTn and BLASTx showed that the 507E08 clone was a novel full-length gene, which codes 203 amino acid of protein and is called human ribosomal protein 14.22 gene. The nucleotide sequence had been submitted to the GenBankTM with the accession number of AF329277. After expression in E.coli., protein yielded a major band of apparent molecular mass 22 kDa on an SDS-PAGE gel. Conclusions cDNA microarray technology can be successfully used to identify differentially expressed genes. The novel full-length gene of human ribosomal protein 14.22 may be correlated with the development of human glioma. 展开更多
关键词 GLIOMA ribosomal proteins GENES
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部